Selected Publication:

SHR Neuro Cancer Cardio Lipid Metab Microb

Nardone, R; Pikija, S; Mutzenbach, JS; Seidl, M; Leis, S; Trinka, E; Sellner, J.
Current and emerging treatment options for spinal cord ischemia.
Drug Discov Today. 2016; 21(10): 1632-1641. Doi: 10.1016/j.drudis.2016.06.015
Web of Science PubMed FullText FullText_MUG

 

Co-authors Med Uni Graz

Pikija Slaven

Altmetrics:

Dimensions Citations:

Plum Analytics:

Scite (citation analytics):

Abstract:

Spinal cord infarction (SCI) is a rare but disabling disorder caused by a wide spectrum of conditions. Given the lack of randomized-controlled trials, contemporary treatment concepts are adapted from guidelines for cerebral ischemia, atherosclerotic vascular disease, and acute traumatic spinal cord injury. In addition, patients with SCI are at risk for several potentially life-threatening but preventable systemic and neurologic complications. Notably, there is emerging evidence from preclinical studies for the use of neuroprotection in acute ischemic injury of the spinal cord. In this review, we discuss the current state of the art for the therapy and prevention of SCI and highlight potential emerging treatment concepts awaiting translational adoption.

Find related publications in this database (using NLM MeSH Indexing)

Animals - administration & dosage

Humans - administration & dosage

Neuroprotective Agents - therapeutic use

Prognosis - administration & dosage

Spinal Cord Ischemia - drug therapy, etiology, prevention & control

© Med Uni Graz • Imprint